Australia
The Conversation (0)
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Helium Evolution
HEVI:CA
Integrated Cyber Solutions
ICS:CC
Purepoint Uranium
PTU:CA
Soma Gold Corp.
SOMA:CA
Trending Reports
Resource
Popular Lists
Investing Ideas
2023 Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
2023 Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
2023 Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
MYND Life Sciences Inc.
CNSX:MYND
Press Releases
More Press Releases
MYND Life Sciences Inc is a life science based, neuro-pharmaceutical drug development company. It is advancing medicines based on neuro-anti-inflammatory substances through rigorous science with an initial focus on major depressive disorder. The company's mission is to further research linking depression and inflammation at the genetic and cellular level to develop a pharmaceutical treatment utilizing compounds found in psychedelics with the initial focus being on psilocybin and its various analogs.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â